1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : BIOTECH
  4. FIRST WAVE BIOPHARMA INC
First Wave BioPharma Inc
XNAS: FWBI
Download real time
4.970.17(3.54%)
28.28% Fall from 52W High
100.6K
XNAS Volume

XNAS 09 Oct, 2026 5:30 PM (EDT)

Portfolio

Alert

My Notes

First Wave BioPharma Inc quarterly and annual earnings report: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents

View Charts

First Wave BioPharma Inc quarterly results: revenue, profit, and P&L – 13 quarter history

Nested row level
Base Level
Reporting Type
Originally Reported
Cell Data
Actual
Table Settings
YoY & New to Old
Nested row level
Base Level
Export
  • NEUTRAL

    Quarterly Revenue First Wave BioPharma Inc Dec-2023 Quarterly Revenue is $0 Million which is growth of 0% YoY.

  • NEGATIVE

    Quarterly Net Profit First Wave BioPharma Inc Dec-2023 Quarterly Net Profit is $-4 Million which is growth of -2.9% YoY.

First Wave BioPharma Inc, Earnings Report - Quarterly Results, standalone, All financials are in USD Million and price data in USD
IndicatorGraphDec '23Sep '23Jun '23Mar '23Dec '22Sep '22Jun '22Mar '22Dec '21Sep '21Jun '21Mar '21
Operating Rev.
-
Cost Of Rev.
------------
Gross Profit
------------
⌄
-3.44.24.12.3-4.45.49.48.830.49.38.2
Operating Profit
--3.4-4.2-4.1-2.34.4-5.4-9.4-8.8-30.4-9.3-8.2
⌄
--0-0
Profit Before Tax
--3.4-4.2-4.1-44.4-5.4-9.6-11.2-30.4-9.3-7.7
Tax
-----------
⌄
--3.5-4.3-4.2-44.2-5.6-10.3-11.3-30.5-12.7-30
Diluted NI Avail to Com Stockholders Ann.
--3.5-4.3-4.2-44.2-5.6-10.3-11.3-30.5-12.7-30
Basic EPS
-2.7-9.2-37.8-254.8-80.1369.6-1,050-2,772714-13,734-6,720-22,764.8
Diluted EPS After ExtraOrdinary
-2.7-9.2-37.8-254.8-80.1364-1,050-2,7721,477.9-13,734-6,720-22,764.8
Number Of Shares End
1.60.40.100.100
Net Income Continuing Discontinued Operations
--3.4-4.2-4.1-44.4-5.4-9.6-11.2-30.4-9.3-7.7
Normalized Income
--3.4-4.2-4.1-44.4-5.4-9.6-8.8-30.4-9.3-7.7
Interest Income
----
Interest
-00000
Net Interest Income
--0-0
EBIT
--3.4-4.2-4.1-44.4-5.4-9.6-11.2-30.4-9.3-7.7
EBITDA
--3.4-4.2-4.1-44.4-5.4-9.6-11-30.3-9.1-7.6
Reconciled Cost Of Rev.
------------
Reconciled Depr.
-00000000.10.10.10.1
Profit From Continuing Operations
--3.4-4.2-4.1-44.4-5.4-9.6-11.2-30.4-9.3-7.7
Normalized EBITDA
--3.4-4.2-4.1-44.4-5.4-9.6-8.7-30.3-9.1-7.6
*All financials are in USD Million and price data in USD
Add metric to table
Search...

First Wave BioPharma Inc competitor comparison and performance snapshot within industry

First Wave BioPharma Inc annual results: revenue, profit, P&L, and margins as of Dec 2023 – 11 year history

Nested row level
Base Level
Reporting Type
Originally Reported
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
  • NEUTRAL

    Annual Revenue First Wave BioPharma Inc Annual Revenue is $0 Million which is growth of 0% YoY.

  • NEGATIVE

    Annual Net Profit First Wave BioPharma Inc Annual Net Profit is $-16 Million which is growth of -8.0% YoY.

First Wave BioPharma Inc, Earnings Report - Annual Results, standalone, All financials are in USD Million and price data in USD
IndicatorGraphCAGR 3 YrsCAGR 5 YrsTTMDec '23Dec '22Dec '21Dec '20Dec '19Dec '18Dec '17Dec '16Dec '15Dec '14
⌄
-
-
 ----
Cost Of Rev. Ann.
-
-
 ----------
Gross Profit Ann.
-
-
 ----------
Operating Exp. Ann.
-15.7%
3.3%
 15.812.756.726.414.713.410.16.64.7
Operating Profit Ann.
-
-
 -15.8-12.7-56.7-26.4-14.7-13.4-10.1-6.6-4.7
⌄
-
-
 -0-0-0-5.8-0.4-0.1-0.9-5.9-1.6-
Other Exp. Ann.
-
-
 -1.9-1.8-0.4---0.1-20.4-
PBT Ann.
-
-
 -15.8-14.6-58.5-32.7-15.2-13.5-11.1-14.6-5.9-
Tax Ann.
-
-
 ------
⌄
-
-
 -16.1-15-84.5-41.7-15.2-13.5-11.1-14.6-5.9-
Diluted NI Avail to Com Stockholders Ann.
-
-
 -16.1-15-84.5-41.7-15.2-13.5-11.1-14.6-5.9-
EPS Ann.
-
-
 -47.9-420-39,774-56,318.9-23,789.5-32,146.4-38,798.5-63,719.1-25,235.1-
Diluted EPS Ann.
-
-
 -47.9-420-39,774-56,318.9-23,789.5-32,146.4-38,798.5-63,719.1-25,235.1-
Number Of Shares End
-
-
 -0.1-
Total Exp. Ann.
-15.7%
3.3%
 15.812.756.726.414.713.410.16.64.7-
Net Income Continuing Discontinued Operations Ann.
-
-
 -15.8-14.6-58.5-32.7-15.2-13.5-11.1-14.6-5.9-
Normalized Income Ann.
-
-
 -15.8-12.9-56.2-32.1-15.2-13.5-11-12.6-6.3-
Interest Income Ann.
-
-
 0------
Interest Ann.
-
-
 0005.80.40.10.95.91.6-
EBITDA Ann.
-
-
 -15.7-14.6-58-26.3-13.7-12.6-9.5-7.9-3.6-
Reconciled Cost Of Rev. Ann.
-
-
 ----------
Reconciled Depr. Ann.
-
-
 000.50.610.80.80.70.7-
Profit From Continuing Operations Ann.
-
-
 -15.8-14.6-58.5-32.7-15.2-13.5-11.1-14.6-5.9-
Normalized EBITDA Ann.
-
-
 -15.7-12.9-55.6-25.7-13.7-12.6-9.3-5.9-4-
*All financials are in USD Million and price data in USD
Add metric to table
Search...
Operating Exp. Ann.
1Y CHG
24.4%
2Y CAGR
-47.2%
3Y CAGR
-15.7%
5Y CAGR
3.3%
7Y CAGR
13.3%
Operating Expenses Annual Cr growth is higher than historical averages.

First Wave BioPharma Inc balance sheet as of Dec 2023: assets, liabilities, reserves, and borrowings – 11 year history

Nested row level
Base Level
Reporting Type
Originally Reported
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
  • POSITIVE

    Total Shareholders Fund First Wave BioPharma Inc Dec-2023 Total Shareholders Fund is $4 Million which is growth of 31.4% YoY.

  • POSITIVE

    Total Assets First Wave BioPharma Inc Dec-2023 Total Assets is $7 Million which is growth of 26.5% YoY.

First Wave BioPharma Inc, Balance Sheet, standalone, All financials are in USD Million and price data in USD
IndicatorGraphCAGR 3 YrsCAGR 5 YrsDec '23Dec '22Dec '21Dec '20Dec '19Dec '18Dec '17Dec '16Dec '15Dec '14
⌄
-18.8%
-1.7%
6.95.411.812.98.97.55.56.86.76.6
⌄
-40.4%
1.9%
3.32.719.615.64.333.83.510.33.9
⌄
-
-4.4%
3.62.7-7.8-2.64.64.51.73.2-7.1-2.3
Total Capitalization Ann.
-
-4.4%
3.62.7-7.8-2.64.64.51.73.2-3.62.6
Tangible Assets Ann.
-
-1%
1.91.1-9.7-7.6-0.72-1.7-0.4-8.1-3
Working Capital Ann.
-
0%
1.80.9-2.9-7.7-0.91.8-0.50.6-6.8-1.8
Invested Capital Ann.
-
-2.2%
4.23.4-7.2-2.16.14.72.13.4-0.5-1.2
Tangible Book Value Ann.
-
-1%
1.91.1-9.7-7.6-0.72-1.7-0.4-11.5-7.9
Borrowings Ann.
10.1%
21.7%
0.80.910.61.60.30.40.26.61.1
Net Debt Ann.
-
-
----1.4---61
Share Issued Ann.
-
-
1.60.1
Number Of Shares End
-
-
-0.1-
*All financials are in USD Million and price data in USD
Add metric to table
Search...
Total Assets Ann.
1Y CHG
27.8%
2Y CAGR
-23.5%
3Y CAGR
-18.8%
5Y CAGR
-1.7%
7Y CAGR
0.2%
Total Assets Annual growth is higher than historical averages.
Total Current Liabilities Ann.
1Y CHG
24%
2Y CAGR
-49.8%
3Y CAGR
-41.6%
5Y CAGR
0.7%
7Y CAGR
4.4%
Total Current Liabilities Annual Cr growth is higher than historical averages.
Total ShareHolders Funds Ann.
1Y CHG
33.3%
5Y CAGR
-4.4%
7Y CAGR
1.7%
Total ShareHolders Funds Annual growth is stable compared to historical averages.

First Wave BioPharma Inc ROE, ROCE, book value, and debt-to-equity ratio as of Dec 2023 – 11 year history

Nested row level
Base Level
Reporting Type
Originally Reported
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
  • NEUTRAL

    Book Value Per Share First Wave BioPharma Inc Book Value Per Share is $0 which is growth of 0% YoY.

  • NEUTRAL

    ROE First Wave BioPharma Inc ROE is 0% which is growth of 0% YoY.

First Wave BioPharma Inc, Ratios, standalone, All financials are in USD Million and price data in USD
IndicatorGraphCAGR 3 YrsCAGR 5 YrsDec '23Dec '22Dec '21Dec '20Dec '19Dec '18Dec '17Dec '16Dec '15Dec '14
RoA Ann. %
-
-
--173.81%-683.98%-382.40%-185.41%-209.03%-181.41%-217.15%-89.44%-
ROE Ann. %
-
-
----4,222.74%-333.90%-441.23%-455.37%---
ROIC %
-
-
--485.2--301.1-19.5-76.4-88.4---
OPM Ann. %
-
-
----------
Inventory Turnover Ratio Ann.
-
-
----------
Asset Turnover Ann. %
-
-
----------
Working Capital Turnover Ann.
-
-
----
Quick Ratio Ann.
-
-
-0.60.70.40.71.40.71.20.20.3
Current Ratio Ann.
-
-
-1.40.80.50.81.60.81.30.20.3
Interest Coverage Ratio Ann.
-
-
--920.3-5,209.3-4.6-34-131.9-11.7-1.5-2.7-
LT Debt To Equity Ann.
-
-
-0.1--------
*All financials are in USD Million and price data in USD
Add metric to table
Search...

First Wave BioPharma Inc cash flow: net, operating, investing, and financing flows as of Dec 2023 – 11 year history

Nested row level
Base Level
Reporting Type
Originally Reported
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
  • POSITIVE

    Cash From Operating Activity First Wave BioPharma Inc Cash From Operating Activity is $-12 Million which is growth of 44.6% YoY.

  • POSITIVE

    Net Cash Flow First Wave BioPharma Inc Net Cash Flow is $2 Million which is growth of 135.6% YoY.

First Wave BioPharma Inc, Cash Flow, standalone, All financials are in USD Million and price data in USD
IndicatorGraphCAGR 3 YrsCAGR 5 YrsDec '23Dec '22Dec '21Dec '20Dec '19Dec '18Dec '17Dec '16Dec '15Dec '14
⌄
-
-
-12.4-22.3-32.3-11.2-14-10.9-7.2-4.5-4.5-
⌄
-
-
-0.5-10.30.1-0-0.3-0-0-0-
⌄
-3.9%
5.4%
15.215.744.817.113.111.765.85-
Cash Plus Cash Eqv. End Of Year Ann.
-15.4%
27.5%
3.71.48.36.10.21.10.61.80.6-
Net Increase In Cash Plus Cash Eqv.s Ann.
-25.9%
36.9%
2.4-6.62.25.9-0.90.5-1.21.20.5-
Cash Plus Cash Eqv. Begin Of Year Ann.
91.3%
18.5%
1.48.36.10.21.10.61.80.60.1-
Income Tax Paid Supplemental Data Ann.
-
-
-----
Interest Paid Supplemental Data Ann.
-
-
000.10-
Capex Ann.
-
-
-0.5--10.3-0-0.1-0-0-0-
Issuance Of Capital Stock Ann.
3.6%
-
15.823.339.814.29.5-55.3-
Issuance Of Debt Ann.
-
-
--0.145.50.31.32.35.8-
Repayment Of Debt Ann.
-
-
-0.6-0.6-1.2-1.9-0.5-0.3-0.4-0.8-
Repurchase Of Capital Stock Ann.
-
-
----------
Free Cash Flow Ann.
-
-
-12.9-22.3-42.6-11.2-14.1-10.9-7.2-4.6-4.5-
*All financials are in USD Million and price data in USD
Add metric to table
Search...
Cash from Financing Act. Ann.
1Y CHG
-3.2%
2Y CAGR
-41.8%
3Y CAGR
-3.9%
5Y CAGR
5.4%
7Y CAGR
14.8%
Cash from Financing Annual Activity is falling faster than historical averages.
×